Shah MK, Shah MA, Shah SD. Risk of hypertension with bevacizumab, an antibody against vascular endothelial growth factor A: a systematic review and meta-analysis. Int J Basic Clin Pharmacol [Internet]. 2019 Sep. 25 [cited 2024 May 5];8(10):2354-60. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/3735